Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

12 juil. 2022 09h00 HE | Source: AXIM BIOTECHNOLOGIES, INC

AXIM Biotechnologies Publishes Study Highlighting Neutralizing Antibody Levels of Poor Vaccine Responders with a Third COVID-19 Vaccine Dose

SAN DIEGO, July 12, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company, announced today their...
24 mai 2022 09h00 HE | Source: AXIM BIOTECHNOLOGIES, INC

AXIM Biotechnologies Completes Optimization of Only FDA-Cleared IgE Rapid Diagnostics Test – In-House Manufacturing Lowers Cost and Eliminates Supply Chain Expenditures

SAN DIEGO, May 24, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting ocular surface...
27 avr. 2022 09h00 HE | Source: AXIM BIOTECHNOLOGIES, INC

AXIM Develops Quantitative Rapid Diagnostic Test for Lacritin; Now Boasts Four Dry Eye Disease Point-of-Care Biomarker Tests

SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting Dry Eye...
22 mars 2022 08h10 HE | Source: Husson University

100% of Husson University Clinical Mental Health Counseling Students Pass the National Counselor Examination on their First Attempt

BANGOR, MAINE, March 22, 2022 (GLOBE NEWSWIRE) -- Husson University announced today that 100% of their clinical mental health counseling students recently passed their National Counselor...
14 janv. 2022 15h35 HE | Source: The Rosen Law Firm PA

NATIONALLY RANKED ROSEN LAW FIRM Encourages Talis Biomedical Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – TLIS

NEW YORK, Jan. 14, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of...
16 déc. 2021 09h00 HE | Source: Kepler Communications

Kepler Communications Announces Testing of ÆTHER™ Network with Spire Global, Inc.

Toronto, Ontario, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Kepler Communications announced today the signing of a contract with Spire Global, Inc. (“Spire”) (NYSE: SPIR), a leading global provider of...
09 nov. 2021 09h00 HE | Source: AXIM BIOTECHNOLOGIES, INC

AXIM Biotechnologies’ Development of Rapid Test for COVID-19 Neutralizing Antibodies is Cited to Demonstrate over 90% Sensitivity and 100% Specificity

SAN DIEGO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting COVID-19...
28 oct. 2021 09h36 HE | Source: The Rosen Law Firm PA

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Reconnaissance Energy Africa Ltd. f/k/a Lund Enterprises Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – RECAF, LGDOF

NEW YORK, Oct. 28, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of...
12 oct. 2021 09h00 HE | Source: AXIM BIOTECHNOLOGIES, INC

AXIM® Biotechnologies Develops Next Generation of its Rapid Neutralizing Antibody Test for COVID-19

SAN DIEGO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological,...
30 août 2021 09h00 HE | Source: AXIM BIOTECHNOLOGIES, INC

AXIM® Biotechnologies’ Manufacturing Partner Empowered Diagnostics Files Amended Emergency Use Authorization with FDA for its Rapid COVID-19 Neutralizing Antibody Test in Whole Blood at Point-of-Care Locations

SAN DIEGO, Aug. 30, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting...

Page précédente

Page suivante